Exocrine Pancreatic Insufficiency
Links shared publicly online about this topic
Coeliac disease and pancreatic exocrine insufficiency
pharmaceutical-int.com — “The following article published by Pharmaceutical International concerns Coeliac disease and pancreatic exocrine insufficiency Introduced by Schebo Biotech.” View full resource at pharmaceutical-int.com
Most Recently Shared on May 8, 2009 at 12:22 am By:
A large number of people that are gluten sensitive also have pancreatic damage. Hence ongoing digestive problems.http://bit.ly/8tCXF
eMJA: Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations
mja.com.au — “(Medical Journal of Australia) Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations” View full resource at mja.com.au
Most Recently Shared on October 18, 2010 at 12:00 am By:
Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations http://bit.ly/9AzsVW
Pancreaze approved for exocrine pancreatic insufficiency - MPR
empr.com — “The FDA has approved Pancreaze (pancrelipase delayed-release capsules, from McNeil Pediatrics) for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis or other conditions.” View full resource at empr.com
Most Recently Shared on April 13, 2010 at 4:27 pm By:
MPR News: Pancreaze approved for exocrine pancreatic insufficiency: The FDA has approved Pancreaze (pancrelipase d... http://bit.ly/bfVFzA
Creon delayed-release capsules available for exocrine pancreatic insufficiency - MPR
empr.com — “Solvay Pharmaceuticals has made available Creon (pancrelipase) delayed-release capsules, a zero-overfill pancreatic enzyme product that targets 100% of the lipase amount indicated on the product labeling.” View full resource at empr.com
Most Recently Shared on July 7, 2009 at 9:48 pm By:
MPR News: Creon delayed-release capsules available for exocrine pancreatic insufficiency: Solvay Pharma.. http://tinyurl.com/mzjwfn
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 15, 2011 at 12:08 am By:
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pa... http://bit.ly/kZWxyW #drug
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 14, 2011 at 11:36 pm By:
FDA Approves Creon (pancrelipase) Infant-Specific Dosage Strength - http://bit.ly/jAdfb4
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
drugs.com — “Trizytek (liprotamase) is a new drug in development for the treatment of pancreatic insufficiency. Trizytek information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on May 5, 2011 at 12:15 am By:
Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic ... http://bit.ly/jOU4X2 #drug
Pancreaze approved for exocrine pancreatic insufficiency - ONA
oncologynurseadvisor.com — “The FDA has approved Pancreaze (pancrelipase delayed-release capsules, from McNeil Pediatrics) for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis or other conditions.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 13, 2010 at 3:24 pm By:
Pancreaze approved for exocrine pancreatic insufficiency http://goo.gl/fb/QlZhQ
Zenpep approved for exocrine pancreatic insufficiency (EPI) - MPR
empr.com — “The FDA has approved Zenpep (pancrelipase delayed-release capsules, from Eurand N.V.), a pancreatic enzyme product (PEP) for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.” View full resource at empr.com
Most Recently Shared on August 31, 2009 at 6:24 pm By:
MPR News: Zenpep approved for exocrine pancreatic insufficiency (EPI): The FDA has approved Zenpep (pan.. http://bit.ly/45RlgT
FDA Approves Pancreatic Enzyme Product, Pancreaze
drugs.com — “Pancreaze (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Pancreaze side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 13, 2010 at 11:44 pm By:
FDA Approves Pancreatic Enzyme Product, Pancreaze - http://bit.ly/c6pGCd
Creon delayed-release capsules approved for exocrine pancreatic insufficiency due to cystic fibrosis - MPR
empr.com — “Creon (pancrelipase, from Solvay Pharmaceuticals) delayed-release capsules, a pancreatic enzyme product (PEP), has received FDA approval for the treatment of exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF) or other conditions under the new guidelines for this class of drugs.” View full resource at empr.com
Most Recently Shared on May 1, 2009 at 5:06 pm By:
MPR News: Creon delayed-release capsules approved for exocrine pancreatic insufficiency due to cystic f.. http://tinyurl.com/cugjqx
Lilly Receives Complete Response Letter From FDA For Liprotamase For The Treatment Of Exocrine Pancreatic Insufficiency
medicalnewstoday.com — “Eli Lilly and Company (NYSE: LLY) has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for liprotamase, a non-porcine pancrea” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2011 at 7:05 am By:
Lilly Receives Complete Response Letter From FDA For Liprotamase For The Treatment Of Exocrine Pancreatic Insufficiency http://mnt.to/3TR6
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency
medicalnewstoday.com — “Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreati” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2011 at 7:05 am By:
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreati... http://mnt.to/3XfN
Pancreatic cancer, exocrine: Treatment - Patient Information [NCI PDQ] - Health.com
health.com — “This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site a” View full resource at health.com
Most Recently Shared on February 5, 2009 at 8:37 pm By:
US Justice Ginsberg has pancreatic cancer. Read why it is so deadly: http://tinyurl.com/cpnwxo
Cancers From B to T: Most common Types of Cancer -Pancreatic Cancer (Exocrine Cancers)
thecancerhealingguide.blogspot.com — “Please note that all articles written by Kyle. J. Norton are for information and education only, please consult with your doctor or related field specialist before applying. http://medicaladvisorjournals.blogspot.com/” View full resource at thecancerhealingguide.blogspot.com
Most Recently Shared on November 16, 2011 at 4:42 pm By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Steve Nenninger
Dr. Steve Nenninger NMD ~ Glutenologist ~ Will only post gluten info with tweets. one per day max.
-
Gastroenterology Upd
Gastroenterology Update is a fortnightly PDF newsletter with the latest Australian and international news.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement

